The European Parkinson's Disease Association (EPDA) is running a major survey to investigate the current standard of care in 36 European countries, including the UK.
Following your fantastic response to our Sinemet shortage call to action, MSD UK has stated that they believe they will meet public demand for the Parkinson's drug Sinemet "by the second half of 2010".
John Birmingham, 48, from Accrington last night featured on The Report on BBC Radio 4, talking about his experiences with the government's controversial assessments for judging people's fitness to work.
Tonight, the BBC Radio 4 current affairs programme, The Report, investigates the controversy surrounding Work Capability Assessments - and our own case study John Birmingham, was interviewed as part of the feature.
Are you a carer of a person with Parkinson's? The national carers' strategy for England is under review and the Government wants to hear views on what form of carer support should be a priority.
We have launched a Fair Care for Parkinson's petition to ask the Government to make sure people with Parkinson's get quality care that meets national standards.
MSD UK has answered your questions about the shortage of Parkinson's drug Sinemet. We feel there's a need for much greater clarity and hope you'll take the opportunity to ask further questions.
What are your experiences of Work Capability Assessments? If you're affected by Parkinson's and have been assessed for Employment and Support Allowance (ESA) please respond to a Government call to evidence.
The Independent Budget Review report for Scotland was published today, which could have major implications for people with Parkinson's in Scotland.
We are calling on older people with Parkinson's who've recently had a hospital stay to submit evidence to the Older People's Commissioner for Wales as part of a review on dignity and respect in hospitals.
As part of our 'Get it on time' campaign, we've produced new DVDs to help hospital and care home staff understand why the timing of Parkinson's drugs is so crucial for people with Parkinson's.
Proper involvement with people with Parkinson's will be crucial in the Government's ambitious NHS reform plans, which give GPs the power and budget to commission services.
Drug manufacturer MSD UK has now agreed to our request to answer your questions about the shortage of Parkinson's drug Sinemet publicly on our online forum.
As a direct result of your actions in our campaign to end the shortage of the Parkinson's drug Sinemet, manufacturer MSD UK has agreed to meet with us today.
We've been working with professional organisations over the shortage of Parkinson's drug Sinemet. Advice for pharmacists is now available from the Royal Pharmaceutical Society.
So far, over 300 people have taken part in our campaign launched this week, demanding answers over the shortage of Parkinson's drug Sinemet. We still want as many people as possible to get involved.
We're calling on all people affected by Parkinson's to join our campaign to maintain supplies of the Parkinson's drug Sinemet.
We're concerned that the Government's announcement in today's Emergency Budget of a medical assessment for Disability Living Allowance (DLA) could mean that people with Parkinson's are wrongly assessed as not needing the allowance.
This week, 2 events were held at Westminster to mark Carers Week, giving MPs the chance to listen to the experiences of carers of people with Parkinson's.
We've been interviewed by BBC Radio Scotland about our 'Get it on time' Scotland petition, which calls for an inquiry into why people with Parkinson's do not get their medication on time.